Beneficial effect of dietary Ephedra sinica on obesity and glucose intolerance in high-fat diet-fed mice

Experimental and Therapeutic Medicine

Volumn 3, Issue 4, 2012, Pages 707-712

  Song, Moon Koo ^a   Um, Jae Young ^a   Jang, Hyeung Jin ^a   Lee, Byung Cheol ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Ephedra sinica; Glucose intolerance; Obesity

Indexed keywords

ACARBOSE; ADIPONECTIN; ANTIDIABETIC AGENT; EPHEDRA SINICA EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCHEMISTRY; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; DRUG EFFECT; EPHEDRA SINICA; EPIDIDYMIS FAT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERGLYCEMIA; LIPID DIET; LIPID METABOLISM; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PLASMA; PROTEIN EXPRESSION; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84863057143     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.462     Document Type: Article

References (21)

1. Costacou T and Mayer-Davis EJ: Nutrition and prevention of type 2 diabetes. Annu Rev Nutr 23: 147-170, 2003.
2. Kahn BB and Flier JS: Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
3. Bray GA and Bellanger T: Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29: 109-117, 2006.
4. Trayhurn P and Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355, 2004.
5. Maeda N, Takahashi M, Funahashi T, et al: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099, 2001.
6. Fruchart JC: Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease. Atherosclerosis 205: 1-8, 2009.
7. Abourashed EA, El-Alfy AT, Khan IA and Walker L: Ephedra in perspective - a current review. Phytother Res 17: 703-712, 2003.
8. Shekelle PG, Hardy ML, Morton SC, et al: Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 289: 1537-1545, 2003.
9. Hackman RM, Havel PJ, Schwartz HJ, et al: Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Int J Obes (Lond) 30: 1545-1556, 2006.
10. Higgins M, D'Agostino R, Kannel W, Cobb J and Pinsky J: Benefits and adverse effects of weight loss. Observations from the Framingham Study. Ann Intern Med 119: 758-763, 1993.
11. Nilsson PM: Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about? Diabetes Care 31 (Suppl 2): 278-283, 2008.
12. Chiasson JL, Josse RG, Gomis R, et al: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359: 2072-2077, 2002.
13. Hanefeld M: The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12: 228-237, 1998.
14. Winzell MS and Ahren B: The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (Suppl 3): 215-219, 2004.
15. Ioannidis I: The road from obesity to type 2 diabetes. Angiology 59: S39-S43, 2008.
16. Braissant O, Foufelle F, Scotto C, Dauca M and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
17. Dyck DJ: Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 34: 396-402, 2009.
18. Diez JJ and Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148: 293-300, 2003.
19. Yamauchi T, Nio Y, Maki T, et al: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339, 2007.
20. Ziccardi P, Nappo F, Giugliano G, et al: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804-809, 2002.
21. Londos C, Brasaemle DL, Schultz CJ, et al: On the control of lipolysis in adipocytes. Ann NY Acad Sci 892: 155-168, 1999.